Temporal specimens collected and tested during the course of treatment identify the loss or elimination of
driver mutations as well as emergence or re-emergence of new clones and new potential therapeutic targets.
Invivoscribe also offers comprehensive MyAML ®, MyHeme ®, MyMRD ®, and custom gene panels, that when used in combination with Invivoscribe's proprietary MyInformatics ® Software can identify and track primary
driver mutations as well as the subclonal architecture and emergence of new driver mutations in patients with hematologic disease.
Invivoscribe's clinical laboratories also offer comprehensive MyAML ®, MyHeme ®, MyMRD ®, and custom gene panels, that when used in combination with Invivoscribe's proprietary MyInformatics ® Software can identify and track primary
driver mutations as well as the subclonal architecture and emergence of new driver mutations in patients with hematologic disease.
Not exact matches
Researchers developed models to examine the influence of
driver mutations —
mutations that promote cancer development — on the initiation and development of gliomas, and how tumor genomic profiles evolve
as the cancer progresses.
«Once identified, we further tested their role
as cancer
drivers, for example by looking at molecules with and without
mutations and comparing their structure and function,» he adds.
Researchers from the University of North Carolina, Chapel Hill, found that the rates of spontaneous
mutation in DNA — a key
driver of evolution — rise very steeply
as temperatures increase.
As the first step in a next generation knowledge system for cancer, the GDC enables and accelerates efforts to identify both high - and low - frequency cancer
driver mutations, assists in revealing the genetic determinants of response to therapy, and informs the composition of clinical trial cohorts.
A major challenge for assessing
driver mutations, such
as epidermal growth factor receptor (EGFR)
mutations, in advanced disease is the scarcity of suitable biopsy tissue for molecular testing.
The generation of new
mutations is a key
driver of evolution but also of susceptibility to rare diseases Fathers pass on four times
as many new
mutations as mothers do, but the maternal contribution is particularly strong in 10 % of the genome that is prone to...
Panels run at the time of diagnosis identify both clinically - actionable
driver mutations associated with the primary tumor,
as well
as the subclonal architecture that may be present.
# 36: The subtitle of Spencer's book suggests, that there is some «intelligence» that drives the climate and fools the scientists — in the same way
as evolution is driven by some intelligent designer that fools the scientist with fossiles indicating that random
mutations, change of environment and selection are
drivers of evolution.